L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea
· Delayed Price · Currency is KRW 23,200
+700 (3.11%)
May 13, 2025, 3:30 PM KST
L&C BIO Co.,LTD Revenue
In the year 2024, L&C BIO Co.,LTD had annual revenue of 72.09B KRW with 9.35% growth.
Revenue
72.09B
Revenue Growth
+9.35%
P/S Ratio
7.30
Revenue / Employee
554.56M
Employees
130
Market Cap
526.29B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| HLB Co., Ltd. | 68.13B |
| SK Biopharmaceuticals | 547.60B |
| PharmaResearch | 350.12B |
| Peptron | 3.15B |